Vermillion, Inc. (VRML) Appoints Bruce Huebner as Interim CEO
Vermillion, a molecular diagnostics company, announced that director Bruce A. Huebner has been appointed as interim CEO. He is following…
Vermillion, a molecular diagnostics company, announced that director Bruce A. Huebner has been appointed as interim CEO. He is following…
EntreMed, a clinical-stage pharmaceutical company developing targeted therapeutics for the treatment of cancer, announced the publication of favorable results of…
Australia-based Prana Biotechnology is focused on commercializing research into age-related neurodegenerative disorders such as Alzheimer’s, Parkinson’s, and Huntington’s diseases. The…
Shoreline Energy Corp. is planning to hold a conference call tomorrow, November 28, 2012, to discuss its recent business developments,…
International Stem Cell Corp., developers of human parthenogenic stem cells (hpSCs), a new class of non-embryonic stem cells that has…
Gemini Explorations has secured some exciting acquisitions in the largely underdeveloped mineral reserve wealth of Colombia, drawing on nearly two…
MediciNova received a notice of allowance from the European Patent Office for a pending patent application which covers the use…
Loans4Less.com is intended to be a valuable source of mortgage and real estate information for individuals interested in residential mortgages,…
When it comes to the digitization, organization, and access of critical information, the key is simplicity and flexibility. Even to…
Hanwha SolarOne, one of world’s top 10 PV manufacturers, has announced the opening of its first office in the Israeli…